TwitterLinkedin

Contact Us

  • News & Events
    • News
    • Webinars
    • Events
  • Resource Library
    • Thought Leadership
    • Fact Flyers
    • Case Studies
    • White Papers
    • Webinars
    • Infographics
    • Video & Animation
  • Careers
    • Working at PharmaLex
    • Your Application Process
    • Current Opportunities
  • Training
Top Bar
Search
PharmaLex Logo
MENUMENU
  • PharmaLex Logo
  • PharmaLex Logo
  • About UsAbout Us
    • About Us
    • Management Team
    • Our Milestones
    • Corporate Social Responsibility
    • What Our Clients Say About Us
  • Our Services
    • Discovery / Non-clinical
          • Go to Discovery / Non-clinical section >>

          • Strategy and Consulting

            • Development Strategy and Gap Analysis
            • Integrated Product Development
            • Market Access Strategy
            • Non-clinical Development Concept
              and Study Design
            • Scientific Advice
            • Scientific Due Diligence
            • Statistical Services
            • Toxicology Services
    • Clinical Development
          • Go to Clinical Development section >>

          • Strategy and Consulting

            • Clinical Program Development
            • Orphan Drug Designation
            • Pediatric Investigation Plan (PIP)
            • Scientific Advice
            • Statistical Services
          • Regulatory Affairs

            • Clinical Trial Applications (CTA)
            • Global Procedure Management
            • Health Authority / Agency Interaction
            • Regulatory Operations
          • Pharmacovigilance

            • Clinical Trial Safety Support
            • Pharmacovigilance Consulting
          • Quality

            • GxP Services
            • IMP Management
            • Interim / Contract QA
            • Quality Systems
            • Tech Transfer / Scale-up
            • Vendor Management and Oversight
    • Authorization / Approval
          • Go to Authorization / Approval section >>

          • Strategy and Consulting

            • Market Access
          • Regulatory Affairs

            • CMC Services
            • Global Procedure Management
            • Health Authority / Agency Interaction
            • Marketing and Labeling Activities
            • Regulatory Operations
            • Scientific, Regulatory and Technical Writing
            • Statistical Services
          • Pharmacovigilance

            • EU QPPV / National QPPV
            • Pharmacovigilance Consulting
          • Quality

            • Commercialization Readiness
            • Commissioning, Qualification, and Validation (CQV)
            • GxP Services
            • Interim / Contract QA
            • PAI Readiness
    • Post-approval / Maintenance
          • Go to Post-approval / Maintenance section >>

          • Strategy and Consulting

            • Environmental Risk Assessment
            • Market Access
          • Regulatory Affairs

            • CMC Services
            • Global End-to-End Outsourcing
            • Global Procedure Management
            • Health Authority / Agency Interaction
            • Marketing and Labeling Activities
            • Mergers and Acquisitions (M&A) Transfers
            • Regulatory Operations
            • Toxicology Services
          • Pharmacovigilance

            • Audit and CAPA Management
            • EU QPPV / National QPPV
            • ICSR Management
            • Literature Screening
            • Pharmacovigilance Systems
            • Safety Writing (PSUR, RMP)
            • Signal Management
          • Quality

            • Commissioning, Qualification, and Validation (CQV)
            • Good Distribution Practice (GDP) Compliance
            • GxP Services
            • Interim / Contract QA
            • Quality Systems
            • Vendor Audit
            • Vendor Management and Oversight
          • Medical Affairs

            • Healthcare Compliance and Medical Approval
            • Medical Information
    • Program Management
          • Go to Program Management section >>

          • Program Management

            • Global End-to-End Outsourcing
            • Global Procedure Management
            • Integrated Product Development
            • Mergers and Acquisitions (M&A) Transfers
    • Featured Expertise
          • Industry Expertise

            • Biopharmaceuticals
            • Consulting
            • Consumer Healthcare
            • Generics
            • Herbal Medicines
            • Medicinal Products
            • MedTech Services
            • Pharmaceutical
            • Veterinary Drugs
          • Service Expertise

            • ATMP / Cell and Gene Therapy
            • Brexit
            • COVID-19 Support
            • Drug Re-purposing / Value-added Medicines
            • GxP Services
            • Market Access
            • Pharmacovigilance Consulting
            • Statistical Services
            • SMARTPHLEX - technology-enabled services
  • Global ReachGlobal Reach
  • Contact usContact us
  • News & Events
    • News
    • Webinars
    • Events
  • Resource Library
    • Thought Leadership
    • Fact Flyers
    • Case Studies
    • White Papers
    • Webinars
    • Infographics
    • Video & Animation
  • Careers
    • Working at PharmaLex
    • Your Application Process
    • Career Opportunities
  • Training
Home > Our Services > Quality Systems

Quality Systems

The Quality Management System (QMS) is the backbone of every life sciences organisation. It is the formalized system that documents procedures, processes and responsibilities for achieving regulatory and quality policies and objectives.

A well designed, tailored and implemented QMS should enable and facilitate your organisation to effectively and efficiently progress through R&D, Clinical and Commercial operations. A one-size-fits-all approach is neither practical nor preferable. Instead, the QMS should be phase-appropriate. It should be fitted and adapted to the organisation’s development stage – whether you’re in early clinical, late clinical or commercial – and to your business model, for example: in-house manufacture versus virtual or contract manufacture.

PharmaLex’s global team of consultants, which includes a number of former US FDA and EU Inspectors, are experts in developing, tailoring and implementing robust phase-appropriate Quality Management Systems to meet these requirements for quality and compliance across the Product Lifecycle.

Want to find out more?

PharmaLex. Confidence beyond compliance.

Contact us for more information

QMS Design

Before QMS development starts, it is critically important to understand the organization in which the QMS will be implemented. This will determine how the core requirements will be developed, as well as identifying additional requirements to fit the organization’s specific needs. This structure can broadly be broken into the following components:

We will guide you through the QMS design process, usually in a virtual or in-person workshop. Our consultants will then prepare a QMS Design report that presents you with a QMS framework and work plan for the development of the QMS. Where there is QMS documentation already available our philosophy is to leverage what’s available, update it where needed and develop new documents to fill the gaps.

QMS Development / Update

Whether it’s a resource, expertise or time constraint, PharmaLex is always ready and available to support your QMS development or QMS update. We can provide all development activities in full, including development / update of: the Quality Manual / Site Master File, Standard Operating Procedures (SOPs), Forms, Quality Agreements, Training Material or Work Instructions.

We work in close association with your QA team throughout the development phase and we can flex up or down as your team needs more or less support.

Electronic Quality Management Systems

If your organization is at an inflection point and requires an Electronic QMS your first step should be a conversation with PharmaLex. Whether you are a looking to change a large enterprise systems or implement your first e-QMS in an SME organization we offer expert advice to ensure that your shortlisted options are the best fit for your organization.

We have experience with many systems of all calibers. We have carefully selected and partnered with the leading system providers and have an in-depth understanding of the strengths of each platform. This detailed knowledge means we are ideally placed to support the deployment, configuration, validation and use of these systems in your organization.

Related News

SMARTRISK
SMARTRISK - risk assessment excipient tool
12th January 2021
medical devices digital health era
Medical Devices in the Digital Health Era
10th December 2020
medical device combination products brexit
BREXIT: Medical Device/Combination Products - Key changes
3rd September 2020

Related Resources

Thought Leadership

  • Can a robust QMS help you achieve customer satisfaction?
  • Product Launch
  • Quality Investigations & CAPAs "Elementary, my dear Watson"​

Fact Flyers

  • Medical Devices for the Pharmaceutical Industry
  • Medical Device Regulations Transition Support
  • GxP - Operate a functional and efficient QMS
  • Medical Device Services

Case Studies

  • End-2-end portfolio maintenance (outsourcing) program
  • Post–M&A PharmaLex program governance
  • Post–M&A pharma infrastructure development
  • Quality Management System

White Papers

  • The Medical Device Regulation – Readiness for May 2021
  • Software, AI and Medical Devices - What's Up?

Webinars

  • QbD and Process Characterization
  • QbD – Analytical Quality by Design
  • The applicability of EU Codes to pharma activities and materials
  • Implementation of an efficient QRM program
  • Vendor Management Programs - Ensuring Success!

Infographics

  • Medical Device Regulations
  • Virtual Auditing for GxP Compliance

Video & Animation

  • SMARTRISK
  • SMARTPHLEX - Technology-enabled Smart Solutions
  • SMARTPHLEX - Technology-enabled Smart Solutions - Part 2

Related Services

  • CMC Services
  • Commercialization Readiness
  • Global Procedure Management
  • GxP Services
  • Health Authority / Agency Interaction
  • Healthcare Compliance and Medical Approval
  • ICSR Management
  • Market Access
  • Marketing and Labeling Activities
  • MedTech Services
  • PAI Readiness
  • PDE and OEL Services
  • SMARTPHLEX
  • SMARTRISK
  • Tech Transfer / Scale-up
  • Toxicology Services
  • Vendor Audit
  • Vendor Management and Oversight
  • Virtual Audits

What our clients say

I just wanted to let you know that the recent EU Codes webinar was excellent. Rina presented a very complex and grey topic in the most clear and digestible manner – a sign of a true expert. The questions in the Q&A were sometimes a little ambiguous but Rina gave clear and relevant answers that provided real clarity.

Richard Blackwell
Medical Team Leader, Multi Tumor Franchise Roche Products Ltd

Thanks so much for your support over the past 30 days. Your commitment and timely communication have made working with you all a pleasant experience.

US Biotech
Senior QA Associate
USEFUL LINKS
  • Home
  • Contact us
  • Imprint
  • Data Protection
  • Terms and Conditions
RECENT TWEETS
Tweets by @PharmaLexGLOBAL
COVID-19 NEWSLETTER SIGN UP

SIGN UP NOW

WHAT OUR CLIENTS SAY
  • What was especially important to me was their ability to get a team, with the right experience, together so quickly.

    Mid-size Biotech
    Head of Outsourcing
PharmaLex
©2021 PharmaLex GmbH. All rights reserved.

ISO9001:2015 LogoEnergie Audit Logo

#AskTheExpert #TogetherBEYONDCOVID19





    Select your state:

    .
    You can unsubscribe at any time at data.protection@pharmalex.com

    If you do not wish to receive any communication from us, you can unsubscribe at any time at. Click here to view our Privacy Policy.

    #TogetherBEYONDCOVID19

    We closely monitor developments and updates surrounding the current outbreak of Coronavirus Disease 2019 (COVID-19) from official sources including the World Health Organisation and are following the guidance and direction of the governments and the local authorities. We are taking this situation very seriously and our number one priority is the safety and business continuity for our customers and colleagues. As ever, we will do everything we can to ensure that services are delivered within the required time and the trusted quality PharmaLex is known for

      Please DO NOT send us event/conference information.
      We will not respond and these will be deleted immediately.





      Select your state:

      .
      You can unsubscribe at any time at
      data.protection@pharmalex.com

      If you do not wish to receive any communication from us, you can unsubscribe at any time at. Click here to view our Privacy Policy.

      Privacy Policy

      This can be specific information about signing up to the newsletter.

      Pellentesque lobortis, tellus at ultrices ullamcorper, lectus tellus consectetur lectus, id consequat leo quam quis eros. Mauris pellentesque tortor a augue pellentesque ultricies. Phasellus sit amet suscipit orci, vel dapibus ligula. Maecenas at pellentesque lectus, sit amet tristique felis. Integer fringilla risus ac neque mollis, at imperdiet lacus sodales. In vehicula orci sed vulputate interdum. Nunc sagittis non nunc eget sollicitudin.

      Maecenas a mattis erat. Phasellus cursus erat non nisl pulvinar ultricies. Aenean id fringilla libero. Orci varius natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Morbi in ultrices elit. Suspendisse egestas hendrerit est. Integer pellentesque nisl ut justo tempus, nec suscipit dolor luctus. Cras vestibulum elementum tincidunt.

      In compliance with the Spanish Law 15/1999, of Protection of Personal Data and in accordance with regulations approved by the Spanish RD 994/1999 inform you that your data will be part of a file located in Friedrichsdorf (Germany), whose ownership belongs to Pharmalex Spain S.L.U. The purpose of these data is the insertion in a potential job selection process. Inform the user that at any time may exercise their right of access, rectification, and deletion of data through email curriculum@pharmalex.com or to this postal address Pharmalex Spain. Coso 103, 50001 Zaragoza, Spain.